Fabagal®

International nonproprietary name

Agalsidase beta

Description

A drug for therapy of the orphan Fabry disease.

Application

For long-term enzyme replacement therapy of patients with confirmed diagnosis of Fabry disease (a rare genetically determined disease, causing kidney problems, neuropathic limb pain, congestive heart failure and stroke).

Product form

Lyophilizate for concentrate for solution for infusion